Group One Trading’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-51,900
Closed -$75.3K 8469
2026
Q1
$75.3K Buy
51,900
+50,500
+3,607% +$80K ﹤0.01% 4964
2025
Q4
$1.93K Sell
1,400
-14,900
-91% -$31.2K ﹤0.01% 7559
2025
Q3
$44.5K Buy
16,300
+5,900
+57% +$21K ﹤0.01% 6061
2025
Q2
$36.3K Buy
10,400
+1,800
+21% +$7.11K ﹤0.01% 5825
2025
Q1
$31.6K Buy
+8,600
New +$31.4K ﹤0.01% 5506
2021
Q4
Sell
-400
Closed -$3K 8815
2021
Q3
$3K Buy
+400
New +$3.84K ﹤0.01% 7888

Other funds holding STIM

Group One Trading's STIM Position: Q2 2026 in Review

Group One Trading reduced its Neuronetics (STIM) stake by 24% in Q2 2026, selling an estimated $7.95K and leaving 17,669 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #5923.

Group One Trading first reported a position in STIM in Q1 2021 and has held it in 10 quarters since. The position peaked at $262K in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Group One Trading held 17,669 shares of Neuronetics worth $23K as of Q2 2026.
  • Group One Trading sold 5,467 Neuronetics shares in Q2 2026, an estimated $7.95K.
  • Neuronetics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5923 holding.
  • Group One Trading first reported a position in Neuronetics in Q1 2021 and has held it in 10 quarters since.
  • Group One Trading's Neuronetics position peaked at $262K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.